APGE - CIK 0001974640
Apogee Therapeutics, Inc. (APGE) reported net income of -$255.84M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$255.84M | -40.5% |
| FY 2024 | -$182.15M | -116.9% |
| FY 2023 | -$83.98M | -111.1% |
| FY 2022 | -$39.78M | - |
Apogee Therapeutics, Inc. (APGE) reported net income of -$255.84M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.